EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Pharmaceutical applications of cyclopropyl containing scaffolds: a review on recent updates

Mohamed T M Nemr, Yaseen A A M Elshaier, Sara Y Ewieda, Mostafa A Abdelaziz

Future Medicinal Chemistry · 02.01.2026 · 18 (1) · 79-88

DOI: 10.1080/17568919.2025.2594969 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Future Medicinal Chemistry, online erschienen am 27.11.2025. Verfasst von Mohamed T M Nemr und 3 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt. Hauptthemen laut MEDLINE: Cyclopropanes. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 93 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Carbocycles have been widely employed in the development of pharmaceutically active scaffolds. Cyclopropane has attracted significant attention from researchers due to its unique chemical properties among carbocycles. Subsequently, this review will focus on cyclopropane-containing pharmaceutical drug products that have been approved by the FDA (Food and Drug Administration) and are used to treat a wide variety of medical conditions. In addition to the synthesis of the cyclopropyl moiety through various chemical reactions, such as the Corey-Chaykovsky reaction and the Simmons-Smith reaction. Several cyclopropane-containing pharmaceutical drugs have been reported to exert significant anti-coagulant effects. Additionally, they also exhibit inhibitory activity against MET, a receptor tyrosine kinase, as well as vascular endothelial growth factor receptor 2 (VEGFR-2). Moreover, they showed cytotoxicity by inhibiting epidermal growth factor receptor (EGFRL858R/T790M). In addition to antidiabetic, anti-Alzheimer, antimalarial, antimicrobial, anti-convulsant and anti-depressant activities. Herein, we present the pharmaceutical applications of cyclopropane-containing derivatives, shedding light on the structure-activity relationship (SAR), along with some commonly reported methods for their synthesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CyclopropanesHumansStructure-Activity RelationshipAnimalsVascular Endothelial Growth Factor Receptor-2Molecular StructureErbB Receptors

Stichwörter der Autor:innen

ADMETCyclopropaneSARpharmaceutical applicationssynthesis

Substanzen

CyclopropanescyclopropaneVascular Endothelial Growth Factor Receptor-2ErbB Receptors

Autor:innen und Institutionen

  • Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
  • Organic & Medicinal Chemistry Department, Faculty of Pharmacy, University of Sadat City, El Sadat, Egypt.
  • Department of Chemistry, College of Wooster, Wooster, OH, USA.

Zitieren

APA

Nemr, M. T. M., Elshaier, Y. A. A. M., Ewieda, S. Y., & Abdelaziz, M. A. (2026). Pharmaceutical applications of cyclopropyl containing scaffolds: a review on recent updates. Future Medicinal Chemistry, 18(1), 79-88. https://doi.org/10.1080/17568919.2025.2594969

Vancouver

Nemr MTM, Elshaier YAAM, Ewieda SY, Abdelaziz MA. Pharmaceutical applications of cyclopropyl containing scaffolds: a review on recent updates. Future Medicinal Chemistry. 2026;18(1):79-88. doi:10.1080/17568919.2025.2594969

BibTeX
@article{Nemr2026,
  author = {Nemr, Mohamed T M and Elshaier, Yaseen A A M and Ewieda, Sara Y and Abdelaziz, Mostafa A},
  title = {Pharmaceutical applications of cyclopropyl containing scaffolds: a review on recent updates},
  journal = {Future Medicinal Chemistry},
  year = {2026},
  volume = {18},
  number = {1},
  pages = {79--88},
  doi = {10.1080/17568919.2025.2594969}
}
Kostenlos starten →